{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:45:47Z","timestamp":1771566347774,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jns.2008.12.029","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:11:43Z","timestamp":1233479503000},"page":"21-25","source":"Crossref","is-referenced-by-count":62,"title":["The prognostic significance of cerebrospinal fluid in multiple sclerosis"],"prefix":"10.1016","volume":"279","author":[{"given":"Sasitorn","family":"Siritho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.12.029_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.jns.2008.12.029_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.12.029_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1468-1331.2004.00822.x","article-title":"CSF isoelectrofocusing in a large cohort of MS and other neurological diseases","volume":"11","author":"Bourahoui","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.12.029_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.35.2.212","article-title":"Oligoclonal bands in multiple sclerosis : clinicopathologic correlation","volume":"35","author":"Farrell","year":"1985","journal-title":"Neurology"},{"issue":"3\u20134","key":"10.1016\/j.jns.2008.12.029_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000111576","article-title":"The accuracy of prevalence rates of multiple sclerosis: a critical review","volume":"29","author":"Poser","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2008.12.029_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.27.2.188","article-title":"Multiple sclerosis in Asia","volume":"27","author":"Kuroiwa","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.12.029_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp.43.2.102","article-title":"Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid","volume":"43","author":"Stendahl-Brodin","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.12.029_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jnnp.60.1.27","article-title":"A study of oligoclonal band negative multiple sclerosis","volume":"60","author":"Zeman","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.12.029_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2006.01.004","article-title":"Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing\u2013remitting MS patients treated with interferon-\u03b2","volume":"244","author":"Annunziata","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.12.029_bib10","unstructured":"Electronic Multiple Sclerosis Monitor System (Imed 4.6) Software Program Serono International SA. Copyright 2006."},{"key":"10.1016\/j.jns.2008.12.029_bib11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.12.029_bib12","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2008.12.029_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.12.029_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0404.2000.102005322.x","article-title":"Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index","volume":"102","author":"Lunding","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2008.12.029_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligocloal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Hans","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.12.029_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.12.029_bib17","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.12.029_bib18","series-title":"Surveys with confidence: a practical guide to survey research using SPSS","author":"Rodeghier","year":"1996"},{"issue":"6","key":"10.1016\/j.jns.2008.12.029_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0404.1995.tb00482.x","article-title":"CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis","volume":"92","author":"Pirttila","year":"1995","journal-title":"Acta Neurol Scand"},{"issue":"2b","key":"10.1016\/j.jns.2008.12.029_bib20","article-title":"Oligoclonal IgG bands in the cerebrospinal fluid of Portuguese patients with multiple sclerosis: negative results indicate benign disease","volume":"63","author":"Jose","year":"2005","journal-title":"Arq Neuro-Psiquiatr"},{"key":"10.1016\/j.jns.2008.12.029_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/01.WNL.0000048202.09147.9E","article-title":"HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands","volume":"60","author":"Kikuchi","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.12.029_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0165-5728(00)00389-1","article-title":"Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis","volume":"111","author":"Nakashima","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.12.029_bib23","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala","year":"2001","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.jns.2008.12.029_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-510X(98)00127-0","article-title":"The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenic backgrounds","volume":"158","author":"Fukazawa","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.12.029_bib25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/01.wnl.0000237343.93389.35","article-title":"Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct","volume":"67","author":"Imrell","year":"2006","journal-title":"Neurology"},{"issue":"suppl 6","key":"10.1016\/j.jns.2008.12.029_bib26","first-page":"71","article-title":"The multiple sclerosis cooperative etiological study in Italy : preliminary analysis of CSF findings","author":"Trojano","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.jns.2008.12.029_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1191\/1352458502ms831oa","article-title":"A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands","volume":"8","author":"Nakashima","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2008.12.029_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0404.2005.00552.x","article-title":"Relevance of colossal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis","volume":"113","author":"Nakashima","year":"2006","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.jns.2008.12.029_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archneur.1989.00520400021013","article-title":"Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes","volume":"46","author":"Muller","year":"1989","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.jns.2008.12.029_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archneur.1990.00530010027014","article-title":"Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis","volume":"47","author":"Baumhefner","year":"1990","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.jns.2008.12.029_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.410120514","article-title":"Correlation of isotopic cisternographic patterns in multiple sclerosis with CSF IgG values","volume":"12","author":"Bartoloni","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.12.029_bib32","unstructured":"Brown. Ellis Horwood Chichester 1986;ch.14:188\u2013203."},{"key":"10.1016\/j.jns.2008.12.029_bib33","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.38.11.1749","article-title":"Sardinian multiple sclerosis is associated with HLA-DR4","volume":"38","author":"Marrosu","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.12.029_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0165-5728(98)00174-X","article-title":"Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFN beta-1a) for relapsing multiple sclerosis","volume":"93","author":"Rudick","year":"1999","journal-title":"J Neuroloimmunol"},{"key":"10.1016\/j.jns.2008.12.029_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1034\/j.1399-0039.2000.550404.x","article-title":"HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis","volume":"55","author":"Sellebjerg","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2008.12.029_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.34.6.769","article-title":"Oligoclonal bands in CSF: twins with MS","volume":"34","author":"Zu","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2008.12.029_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.62.2.168","article-title":"Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS","volume":"62","author":"Freedman","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2008.12.029_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.56.8.1084","article-title":"MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS","volume":"56","author":"Saiz","year":"2001","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08006709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08006709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T03:56:10Z","timestamp":1545450970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08006709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0022510X08006709"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.12.029","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}